[PDF][PDF] Effectiveness, safety, and comparative side effects

SEK Bradley, CB Polis, EA Micks… - … technology. 22nd ed …, 2023 - samples.jblearning.com
• More than 1 million pregnancies occur every year in the United States among people using
contraception.• Contraceptive effectiveness is one of several key factors that most people …

Oral contraceptive use among women in the military and the general US population

L Enewold, LA Brinton, KA McGlynn… - Journal of Women's …, 2010 - liebertpub.com
Objective: To compare oral contraceptive (OC) use during a 12-month period among women
aged 18–39 years in the US military and the general US population using data from the …

Contraception for midlife women: a review

TA Miller, RH Allen, AM Kaunitz, CA Cwiak - Menopause, 2018 - journals.lww.com
Family planning represents a key component of reproductive health care. Accordingly, the
provision of contraception must span the reproductive age spectrum, including …

The use of hormonal contraception and its protective role against endometrial and ovarian cancer

GF Grimbizis, BC Tarlatzis - Best practice & research Clinical obstetrics & …, 2010 - Elsevier
Hormonal contraception has a protective effect over ovarian and endometrial cancer
development. Relative risk of ovarian cancer decreases by∼ 20% for each 5 years of use; it …

Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement …

A Gadducci, N Biglia, S Cosio, P Sismondi… - Gynecological …, 2010 - Taylor & Francis
BRCA1 and BRCA2 mutation carriers have a 54–85% and 45% lifetime risk of developing
breast cancer, respectively, and a 18–60% and 11–27% lifetime risk of developing ovarian …

Menstrual factors, reproductive history and liver cancer risk: findings from a prospective cohort study in Chinese women

JY Tuo, HL Li, J Wang, J Fang, YT Tan… - … , Biomarkers & Prevention, 2022 - AACR
Background: Many studies suggested that menstrual and reproductive factors affected the
gender disparity in liver carcinogenesis, but the results were inconsistent. Moreover, there …

Screening women for oral contraception: can family history identify inherited thrombophilias?

DA Grimes, GS Stuart, EE Levi - Obstetrics & Gynecology, 2012 - journals.lww.com
OBJECTIVE: Screening for inherited thrombophilias with laboratory tests is impractical
before starting women on combined oral contraceptives. As an alternative, some …

Association of combined estrogen–progestogen and progestogen-only contraceptives with the development of cancer

WV Williams, LA Mitchell, SK Carlson… - The Linacre …, 2018 - journals.sagepub.com
Combined estrogen–progestogen contraceptives (oral contraceptives or OCs) and
progestogen-only contraceptives (POCs) are synthetic steroids that bind to steroid hormone …

Oral contraceptive use and colorectal cancer in the nurses' health study I and II

BM Charlton, K Wu, X Zhang, EL Giovannucci… - … Biomarkers & Prevention, 2015 - AACR
Background: It remains unclear if oral contraceptive (OC) use is associated with the
incidence of colorectal cancer. Few studies have examined this association by duration of …

Risk of gynecological cancers in cholecystectomized women: A large nationwide cohort study

E Kharazmi, K Sundquist, J Sundquist, M Fallah… - Cancers, 2022 - mdpi.com
Simple Summary Gallstones affect women more frequently than men. Symptomatic
gallstones are treated with surgical removal of the gallbladder. Overweight, obesity, and …